Paradoxical inflammatory switches during biologic therapy: a mechanistic framework, clinical algorithm, and pediatric illustrations

• by Małgorzata Kowacka, Michał Dec, Hubert Arasiewicz

• May 20, 2026

Ivarmacitinib Eased Refractory PCA: Case Report

Off-label ivarmacitinib rapidly relieved pruritus and improved skin lesions in a patient with refractory primary cutaneous amyloidosis, according to a case report.

• by Andrea Surnit

• May 20, 2026

• 4 min

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

• by Andrea Surnit

• May 14, 2026

• 3 min

GLP-1 Agents May Reduce Psoriasis Severity

National Psoriasis Foundation review highlights limited evidence and potential metabolic links.

• by Andrea Surnit

• May 5, 2026

• 4 min